|
Market Closed -
OTC Markets
22:07:17 21/04/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.75 USD | -4.83% |
|
-1.87% | +19.59% |
| 08-17 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,143B 25.95B 22.42B 21.09B 19.17B 36.05B 2,487B 36.58B 247B 96.96B 1,244B 97.45B 95.33B | P/E 2027 * |
11.2x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4,101B 25.69B 22.19B 20.88B 18.98B 35.69B 2,462B 36.21B 245B 95.98B 1,231B 96.46B 94.37B | EV / Sales 2027 * |
1.77x | EV / Sales 2028 * | 1.73x |
| Free-Float |
98.88% | Yield 2027 * |
3.47% | Yield 2028 * | 3.59% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -4.83% | ||
| 1 week | -1.87% | ||
| Current month | +6.78% | ||
| 1 month | +15.17% | ||
| 3 months | +0.64% | ||
| 6 months | -2.57% | ||
| Current year | +19.59% |
| 1 week | 13.45 |  | 16.15 |
| 1 month | 12.85 | | 16.15 |
| Current year | 11.95 | | 17.85 |
| 1 year | 9.85 | | 17.85 |
| 3 years | 8.4 | | 17.85 |
| 5 years | 8.4 | | 17.95 |
| 10 years | 8.4 | | 18.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.83% | -1.87% | - | - | 25.69B | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,055B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 632B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 442B | |
| +1.35% | -2.17% | +40.98% | +41.50% | 351B | |
| +1.75% | -0.24% | +25.28% | +40.46% | 290B | |
| +2.13% | -0.32% | +0.58% | +10.77% | 243B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 227B | |
| +1.35% | -3.53% | -14.72% | -52.63% | 200B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 172B | |
| Average | +1.68% | +0.10% | +30.42% | +49.50% | 401.39B | |
| Weighted average by Cap. | +2.73% | +0.23% | +43.70% | +68.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,315B 14.51B 12.53B 11.79B 10.71B 20.15B 1,390B 20.45B 138B 54.19B 695B 54.46B 53.28B | 2,137B 13.39B 11.56B 10.88B 9.89B 18.59B 1,283B 18.87B 128B 50B 641B 50.26B 49.16B |
| Net income | 356B 2.23B 1.93B 1.81B 1.65B 3.1B 214B 3.14B 21.25B 8.33B 107B 8.37B 8.19B | 333B 2.08B 1.8B 1.69B 1.54B 2.89B 200B 2.94B 19.86B 7.78B 99.84B 7.82B 7.65B |
| Net Debt | -41.87B -262M -227M -213M -194M -364M -25.14B -370M -2.5B -980M -12.57B -985M -964M | -439B -2.75B -2.38B -2.24B -2.03B -3.82B -264B -3.88B -26.22B -10.28B -132B -10.33B -10.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | $15.20 | -3.80% | 348 |
| 17/08/26 | $15.80 | -2.17% | 1,995 |
| 14/08/26 | $16.15 | +20.07% | 11,200 |
| 13/08/26 | $13.45 | -16.20% | 410 |
| 11/08/26 | $16.05 | +7.72% | 966 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMF Stock
Select your edition
All financial news and data tailored to specific country editions
